Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase.

Bhattacharya C, Dey AS, Ayon NJ, Gutheil WG, Mukherji M.

J Vis Exp. 2018 Oct 15;(140). doi: 10.3791/57798.

PMID:
30371677
2.

Convenient expression, purification and quantitative liquid chromatography-tandem mass spectrometry-based analysis of TET2 5-methylcytosine demethylase.

Jaiswal M, Bhar S, Vemula H, Prakash S, Ponnaluri VKC, Gutheil WG, Mukherji M.

Protein Expr Purif. 2017 Apr;132:143-151. doi: 10.1016/j.pep.2017.02.003. Epub 2017 Feb 8.

PMID:
28188826
3.

HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies.

Subhani S, Vavilala DT, Mukherji M.

Angiogenesis. 2016 Jul;19(3):257-73. doi: 10.1007/s10456-016-9510-0. Epub 2016 May 4. Review.

PMID:
27146677
4.

Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases.

Vavilala DT, Ponnaluri VK, Kanjilal D, Mukherji M.

PLoS One. 2014 Nov 25;9(11):e113717. doi: 10.1371/journal.pone.0113717. eCollection 2014.

5.

Prohexadione, a plant growth regulator, inhibits histone lysine demethylases and modulates epigenetics.

Vavilala DT, Reddy S, Sachchidanand, Prakash S, Ponnaluri VKC, Kumar A, Mukherji M.

Toxicol Rep. 2014 Nov 4;1:1152-1161. doi: 10.1016/j.toxrep.2014.10.026. eCollection 2014.

6.

Ritonavir inhibits HIF-1α-mediated VEGF expression in retinal pigment epithelial cells in vitro.

Vadlapatla RK, Vadlapudi AD, Pal D, Mukherji M, Mitra AK.

Eye (Lond). 2014 Jan;28(1):93-101. doi: 10.1038/eye.2013.240. Epub 2013 Nov 8.

7.

Honokiol inhibits pathological retinal neovascularization in oxygen-induced retinopathy mouse model.

Vavilala DT, O'Bryhim BE, Ponnaluri VK, White RS, Radel J, Symons RC, Mukherji M.

Biochem Biophys Res Commun. 2013 Sep 6;438(4):697-702. doi: 10.1016/j.bbrc.2013.07.118. Epub 2013 Aug 3.

PMID:
23921228
8.

Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas.

Ponnaluri VK, Vavilala DT, Prakash S, Mukherji M.

Biochem Biophys Res Commun. 2013 Aug 16;438(1):71-7. doi: 10.1016/j.bbrc.2013.07.028. Epub 2013 Jul 18.

PMID:
23872148
9.

Molecular expression and functional activity of efflux and influx transporters in hypoxia induced retinal pigment epithelial cells.

Vadlapatla RK, Vadlapudi AD, Ponnaluri VK, Pal D, Mukherji M, Mitra AK.

Int J Pharm. 2013 Sep 15;454(1):444-52. doi: 10.1016/j.ijpharm.2013.06.044. Epub 2013 Jul 1.

10.

A mechanistic overview of TET-mediated 5-methylcytosine oxidation.

Ponnaluri VK, Maciejewski JP, Mukherji M.

Biochem Biophys Res Commun. 2013 Jun 28;436(2):115-20. doi: 10.1016/j.bbrc.2013.05.077. Epub 2013 May 29. Review.

PMID:
23727577
11.

Honokiol inhibits HIF pathway and hypoxia-induced expression of histone lysine demethylases.

Vavilala DT, Ponnaluri VK, Vadlapatla RK, Pal D, Mitra AK, Mukherji M.

Biochem Biophys Res Commun. 2012 Jun 8;422(3):369-74. doi: 10.1016/j.bbrc.2012.04.143. Epub 2012 May 3.

PMID:
22580280
12.

Spinocerebellar Ataxia Type 12.

Margolis RL, Holmes SE, Srivastava AK, Mukherji M, Sinha KK.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2004 Oct 1 [updated 2011 Nov 17].

13.

Hypoxia induced expression of histone lysine demethylases: implications in oxygen-dependent retinal neovascular diseases.

Ponnaluri VK, Vadlapatla RK, Vavilala DT, Pal D, Mitra AK, Mukherji M.

Biochem Biophys Res Commun. 2011 Nov 18;415(2):373-7. doi: 10.1016/j.bbrc.2011.10.075. Epub 2011 Oct 20.

PMID:
22037463
14.

Gray matter volume deficits in spinocerebellar ataxia: an optimized voxel based morphometric study.

Goel G, Pal PK, Ravishankar S, Venkatasubramanian G, Jayakumar PN, Krishna N, Purushottam M, Saini J, Faruq M, Mukherji M, Jain S.

Parkinsonism Relat Disord. 2011 Aug;17(7):521-7. doi: 10.1016/j.parkreldis.2011.04.008. Epub 2011 May 20.

PMID:
21600833
15.

Microtiter plate-based assay for inhibitors of penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus.

Bobba S, Ponnaluri VK, Mukherji M, Gutheil WG.

Antimicrob Agents Chemother. 2011 Jun;55(6):2783-7. doi: 10.1128/AAC.01327-10. Epub 2011 Mar 14.

16.

Studies on substrate specificity of Jmjd2a-c histone demethylases.

Ponnaluri VK, Vavilala DT, Mukherji M.

Biochem Biophys Res Commun. 2011 Feb 25;405(4):588-92. doi: 10.1016/j.bbrc.2011.01.073. Epub 2011 Jan 23.

PMID:
21266164
17.

Short communication: Lack of immune response in rapid progressor morphine-dependent and SIV/SHIV-infected rhesus macaques is correlated with downregulation of TH1 cytokines.

Rivera-Amill V, Kumar R, Noel RJ Jr, Garcia Y, Rodriguez IV, Martinez M, Sariol CA, Kraiselburd E, Iszard M, Mukherji M, Kumar S, Giavedoni LD, Kumar A.

AIDS Res Hum Retroviruses. 2010 Aug;26(8):919-22. doi: 10.1089/aid.2010.0012.

18.

Identification of non-histone substrates for JMJD2A-C histone demethylases.

Ponnaluri VK, Vavilala DT, Putty S, Gutheil WG, Mukherji M.

Biochem Biophys Res Commun. 2009 Dec 11;390(2):280-4. doi: 10.1016/j.bbrc.2009.09.107. Epub 2009 Sep 30.

PMID:
19799855
19.

A phosphoproteomic analysis of the ErbB2 receptor tyrosine kinase signaling pathways.

Mukherji M, Brill LM, Ficarro SB, Hampton GM, Schultz PG.

Biochemistry. 2006 Dec 26;45(51):15529-40. Epub 2006 Dec 19.

PMID:
17176074
20.

Genome-wide functional analysis of human cell-cycle regulators.

Mukherji M, Bell R, Supekova L, Wang Y, Orth AP, Batalov S, Miraglia L, Huesken D, Lange J, Martin C, Sahasrabudhe S, Reinhardt M, Natt F, Hall J, Mickanin C, Labow M, Chanda SK, Cho CY, Schultz PG.

Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14819-24. Epub 2006 Sep 25.

21.

Phosphoproteomics in analyzing signaling pathways.

Mukherji M.

Expert Rev Proteomics. 2005 Jan;2(1):117-28. Review.

PMID:
15966857
22.

Studies on the specificity of unprocessed and mature forms of phytanoyl-CoA 2-hydroxylase and mutation of the iron binding ligands.

Searls T, Butler D, Chien W, Mukherji M, Lloyd MD, Schofield CJ.

J Lipid Res. 2005 Aug;46(8):1660-7. Epub 2005 Jun 1.

23.

Site-specific PEGylation of proteins containing unnatural amino acids.

Deiters A, Cropp TA, Summerer D, Mukherji M, Schultz PG.

Bioorg Med Chem Lett. 2004 Dec 6;14(23):5743-5.

PMID:
15501033
24.

Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.

Brill LM, Salomon AR, Ficarro SB, Mukherji M, Stettler-Gill M, Peters EC.

Anal Chem. 2004 May 15;76(10):2763-72.

PMID:
15144186
25.

Role of phytanoyl-CoA 2-hydroxylase in phytanic acid metabolism.

Lloyd MD, Mukherji M, Kershaw NJ, Chien W, Wierzbicki AS, Schofield CJ.

Adv Exp Med Biol. 2003;544:303-4. No abstract available.

PMID:
14713244
26.

Adding amino acids with novel reactivity to the genetic code of Saccharomyces cerevisiae.

Deiters A, Cropp TA, Mukherji M, Chin JW, Anderson JC, Schultz PG.

J Am Chem Soc. 2003 Oct 1;125(39):11782-3.

PMID:
14505376
27.

An expanded eukaryotic genetic code.

Chin JW, Cropp TA, Anderson JC, Mukherji M, Zhang Z, Schultz PG.

Science. 2003 Aug 15;301(5635):964-7.

28.

The chemical biology of branched-chain lipid metabolism.

Mukherji M, Schofield CJ, Wierzbicki AS, Jansen GA, Wanders RJ, Lloyd MD.

Prog Lipid Res. 2003 Sep;42(5):359-76. Review.

PMID:
12814641
29.

The role of arginine residues in substrate binding and catalysis by deacetoxycephalosporin C synthase.

Lipscomb SJ, Lee HJ, Mukherji M, Baldwin JE, Schofield CJ, Lloyd MD.

Eur J Biochem. 2002 Jun;269(11):2735-9.

30.

Utilization of sterol carrier protein-2 by phytanoyl-CoA 2-hydroxylase in the peroxisomal alpha oxidation of phytanic acid.

Mukherji M, Kershaw NJ, Schofield CJ, Wierzbicki AS, Lloyd MD.

Chem Biol. 2002 May;9(5):597-605.

31.

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.

Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ.

Cell. 2001 Oct 5;107(1):43-54.

32.

Structure-function analysis of phytanoyl-CoA 2-hydroxylase mutations causing Refsum's disease.

Mukherji M, Chien W, Kershaw NJ, Clifton IJ, Schofield CJ, Wierzbicki AS, Lloyd MD.

Hum Mol Genet. 2001 Sep 1;10(18):1971-82.

PMID:
11555634
33.

Studies on phytanoyl-CoA 2-hydroxylase and synthesis of phytanoyl-coenzyme A.

Kershaw NJ, Mukherji M, MacKinnon CH, Claridge TD, Odell B, Wierzbicki AS, Lloyd MD, Schofield CJ.

Bioorg Med Chem Lett. 2001 Sep 17;11(18):2545-8.

PMID:
11549466
34.

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, von Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ.

Science. 2001 Apr 20;292(5516):468-72. Epub 2001 Apr 5.

35.
36.

Intravascular contrast media and the blood-brain barrier. Testing the new nonionic agent ioxilan.

Harnish PP, Krutchen A, Mukherji M.

Invest Radiol. 1989 Jan;24(1):34-6.

PMID:
2917821
37.

Opiate involvement in contrast media-induced blood pressure changes.

Harnish PP, Mukherji M, Northington FK, Kido DK.

Invest Radiol. 1987 Nov;22(11):905-7.

PMID:
3429188
38.

Physiologic effects of contrast media in the rabbit.

Harnish P, Mukherji M, Kido DK.

Invest Radiol. 1987 Nov;22(11):901-4.

PMID:
3429187
39.

Tonsillectomy as an aid to cleft palate operation.

Mukherji MM, Chanda B.

J Indian Med Assoc. 1974 Jul 16;63(2):45-50. No abstract available.

PMID:
4436554
40.

Giant neurofibroma of the head and neck.

Mukherji MM.

Plast Reconstr Surg. 1974 Feb;53(2):184-9. No abstract available.

PMID:
4812027
41.

Filarial elephantiasis of the leg.

Mukherji M, Benerjee D.

Clin Plast Surg. 1974 Jan;1(1):83-91. No abstract available.

PMID:
4609666
42.

Cheek flap for short palates.

Mukherji MM.

Cleft Palate J. 1969 Oct;6:415-20. No abstract available.

PMID:
5260747
43.
44.

Histochemical changes in the kidney of toad (Bufo melanostictus) after carbon tetrachloride intoxication.

Biswas NM, Mukherji M.

Anat Anz. 1968;123(1):100-4. No abstract available.

PMID:
5720219
45.

Effect of excess vitamin A on pituitary-gonadal axis in rats.

Biswas NM, Mukherji M.

Anat Anz. 1968;123(3):337-41. No abstract available.

PMID:
4885084
46.

Adrenal cortex in stress and hibernation--a histochemical study in toad (Bufo melanostictus).

Mukherji M.

Acta Histochem. 1968;29(2):297-303. No abstract available.

PMID:
4186700
47.

Ascorbic acid and testicular activity in heat-exposed toad (Bufo melanostictus).

Biswas NM, Mukherji M.

Experientia. 1967 Aug 15;23(8):667. No abstract available.

PMID:
6058912
48.

Observations on the histochemical basis of reticulin staining (bromine-silver method).

Mukherji M, Sen PB.

Acta Anat (Basel). 1967;66(3):365-74. No abstract available.

PMID:
4168040
49.

Gonadotrophic control of lamina propria and laminar collagen of testis.

Mukherji M.

Experientia. 1966 Jul 15;22(7):466-7. No abstract available.

PMID:
5964108
50.

Effect of carbon tetrachloride in the gonadal activity of female rats.

Chatterjee A, Mukherji M.

Endokrinologie. 1966 Jun;50(1):1-4. No abstract available.

PMID:
6011102

Supplemental Content

Loading ...
Support Center